These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 16796558)

  • 1. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The many roles of computation in drug discovery.
    Jorgensen WL
    Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based drug screening and ligand-based drug screening with machine learning.
    Fukunishi Y
    Comb Chem High Throughput Screen; 2009 May; 12(4):397-408. PubMed ID: 19442067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based drug design: docking and scoring.
    Kroemer RT
    Curr Protein Pept Sci; 2007 Aug; 8(4):312-28. PubMed ID: 17696866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring functions for prediction of protein-ligand interactions.
    Wang JC; Lin JH
    Curr Pharm Des; 2013; 19(12):2174-82. PubMed ID: 23016847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergies of virtual screening approaches.
    Muegge I
    Mini Rev Med Chem; 2008 Aug; 8(9):927-33. PubMed ID: 18691150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus scoring for protein-ligand interactions.
    Feher M
    Drug Discov Today; 2006 May; 11(9-10):421-8. PubMed ID: 16635804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening for the discovery of bioactive natural products.
    Rollinger JM; Stuppner H; Langer T
    Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N; Zaliani A
    J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.